1 / 11

Ankylosing Spondylitis Market Size, Share, Growth And Forecast To 2028

Ankylosing Spondylitis (AS), also known as Bechterew disease is the rare type of arthritis causing stiffness and intense pain in the individualu2019s spine, starting from lower back sacral bones. AS could also spread to the neck region and damage to other adjoining joints. Ankylosis simply means bone fusion and hard connective tissue and spondylitis means inflammation in the spine and lower part of the vertebrae.

priyanka1988
Télécharger la présentation

Ankylosing Spondylitis Market Size, Share, Growth And Forecast To 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ankylosing Spondylitis Market Market Size Worth $8.45 Billion By 2028 | CAGR: 8.5%

  2. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 “According to Polaris Market Research report, Ankylosing Spondylitis market is witnessing a major transformation and is projected to reach $8.45 Billion By 2028 registering a CAGR of 8.5% during the forecast period 2021 to 2028.” The global Ankylosing Spondylitis market growth is driven by some of the key factors such as growing awareness among consumers, increasing investments by private-public organizations, and favorable government policies. Additionally, many prominent players present in the market are concentrating on the adoption of new technology and product launches to obtain a competitive edge, which in turn contributes to the Ankylosing Spondylitis market growth. The regulatory agencies are also playing a key role as the major driving force for the market, by safeguarding the quality of product/service offerings as well as accelerating new approvals. Ankylosing Spondylitis Market Report Scope: The study provides a comprehensive view of the Ankylosing Spondylitis market by segmenting it based on Drug, Treatment Type and region. All the segments of the market have been thoroughly analyzed based on present and future trends. The research report has identified the key segments contributing most to the Ankylosing Spondylitis market growth in terms of revenue along with other vital factors impacting the market dynamics. Further, the market analysis covered in the report also answers the imperative question for new entrants and existing players operating in the market. Browse Detailed Research Report On Ankylosing Spondylitis Market Analysis: https://www.polarismarketresearch.com/industry-analysis/ankylosing-spondylitis-market - 2 -

  3. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 By Drug By Treatment Type By Region •Cosentyx •Humira •Simponi •Remicade •Enbrel •Cimzia •Others •Painkillers and non- steroidal anti- inflammatory drugs (NSAIDs) •Disease-modifying anti- rheumatic drugs (DMARDs) •Biological therapies •Steroids •Physical therapies •Surgery •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) Impact Analysis of COVID-19 on Ankylosing Spondylitis Market The global Ankylosing Spondylitis market is anticipated to continue its growth amid the covid-19 pandemic. After giving insightful information on market behavior pre and post COVID-19 pandemic, the report also sheds light on the key strategic moves to overcome the adverse impact of COVID-19 on business and turn the positive impact into a lucrative opportunity. Regional Outlook The regional market of North America is witnessing a significant rise in the growth rate and is expected to account for the largest market share over the forecast period. The market is flourishing as a result of its increasing application scope and ample availability of vital resources. During the forecast period, the Asia Pacific region is estimated to garner the highest CAGR for the Ankylosing Spondylitis market, owing to the presence of several leading local and international players operating in the regional market. Gain access to our latest research report that includes a detailed analysis of the COVID-19 pandemic influencing the Ankylosing Spondylitis market in different regions and how market players devising effective strategies to mitigate the effect of the pandemic: https://www.polarismarketresearch.com/industry- analysis/ankylosing-spondylitis-market/speak-to-analyst Competitive Landscape Leading companies holding significant market shares in the Ankylosing Spondylitis market are analyzed considering their market shares, growth rates, market revenue, business strategies, and latest developments. - 3 -

  4. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 Recent events for these major companies such as acquisitions, research initiatives, technological advancements, new solution/product launches, and geographical expansions considered in finalizing their position in the market. According to Polaris Market Research, the leading players with a noteworthy share in the Ankylosing Spondylitis market include AbbVie, Inc., Pfizer, Inc., Novartis AG, Amgen, Inc., Johnson & Johnson Services, Inc., Eli Lilly and Company, UCB, Inc., and Merck & Co., Inc. Request for sample: https://www.polarismarketresearch.com/industry-analysis/ankylosing-spondylitis- market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Ankylosing Spondylitis Market Insights 4.1.Ankylosing Spondylitis – Industry snapshot 4.2.Ankylosing Spondylitis Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. Strong drug pipeline 4.2.1.2. Patient awareness regarding its ill effects 4.2.2.Restraints and Challenges 4.2.2.1. High cost of available treatment options 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) - 4 -

  5. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Ankylosing Spondylitis Market Industry trends 5.Ankylosing Spondylitis Market Assessment by Drug 5.1.Key Findings 5.2.Introduction 5.2.1.Global Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 5.3.Cosentyx 5.3.1.Global Ankylosing Spondylitis Market, by Cosentyx, by Region, 2016 – 2028 (USD Million) 5.4.Humira 5.4.1.Global Ankylosing Spondylitis Market, by Humira, by Region, 2016 – 2028 (USD Million) 5.5.Simponi 5.5.1.Global Ankylosing Spondylitis Market, by Simponi, by Region, 2016 – 2028 (USD Million) 5.6.Remicade 5.6.1.Global Ankylosing Spondylitis Market, by Remicade, by Region, 2016 – 2028 (USD Million) 5.7.Enbrel 5.7.1.Global Ankylosing Spondylitis Market, by Enbrel, by Region, 2016 – 2028 (USD Million) 5.8.Cimzia 5.8.1.Global Ankylosing Spondylitis Market, by Cimzia, by Region, 2016 – 2028 (USD Million) 5.9.Others 5.9.1.Global Ankylosing Spondylitis Market, by Others, by Region, 2016 – 2028 (USD Million) 6.Global Ankylosing Spondylitis Market, by Treatment Type 6.1.Key Findings 6.2.Introduction 6.2.1.Global Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 6.3.Painkillers and non-steroidal anti-inflammatory drugs (NSAIDs) - 5 -

  6. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 6.3.1.Global Ankylosing Spondylitis Market, by Painkillers and non-steroidal anti- inflammatory drugs (NSAIDs), By Region, 2016 – 2028 (USD Million) 6.4.Disease-modifying anti-rheumatic drugs (DMARDs) 6.4.1.Global Ankylosing Spondylitis Market, by Disease-modifying anti-rheumatic drugs (DMARDs), by Region, 2016 – 2028 (USD Million) 6.5.Biological therapies 6.5.1.Global Ankylosing Spondylitis Market, by Biological therapies, by Region, 2016 – 2028 (USD Million) 6.6.Steroids 6.6.1.Global Ankylosing Spondylitis Market, by Steroids, by Region, 2016 – 2028 (USD Million) 6.7.Physical therapies 6.7.1.Global Ankylosing Spondylitis Market, by Physical therapies, by Region, 2016 – 2028 (USD Million) 6.8.Surgery 6.8.1.Global Ankylosing Spondylitis Market, by Surgery, by Region, 2016 – 2028 (USD Million) 7.Ankylosing Spondylitis Market Assessment by Geography 7.1.Key findings 7.2.Introduction 7.2.1.Ankylosing Spondylitis Market Assessment, By Geography, 2016 – 2028 (USD Million) 7.3.Ankylosing Spondylitis Market – North America 7.3.1.North America: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.3.2.North America: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.3.3.Ankylosing Spondylitis Market – U.S. 7.3.3.1. U.S.: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.3.3.2. U.S.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.3.4.Ankylosing Spondylitis Market – Canada 7.3.4.1. Canada: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.3.4.2. Canada.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.Ankylosing Spondylitis Market – Europe 7.4.1.Europe: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) - 6 -

  7. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 7.4.2.Europe: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.3.Ankylosing Spondylitis Market – UK 7.4.3.1. UK: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.3.2. UK: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.4.Ankylosing Spondylitis Market – France 7.4.4.1. France: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.4.2. France: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.5.Ankylosing Spondylitis Market – Germany 7.4.5.1. Germany: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.5.2. Germany: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.6.Ankylosing Spondylitis Market – Italy 7.4.6.1. Italy: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.6.2. Italy: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.7.Ankylosing Spondylitis Market – Spain 7.4.7.1. Spain: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.7.2. Spain: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.8.Ankylosing Spondylitis Market – Netherlands 7.4.8.1. Netherlands: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.8.2. Netherlands: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.4.9.Ankylosing Spondylitis Market – Austria 7.4.9.1. Austria: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.4.9.2. Austria: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.Ankylosing Spondylitis Market – Asia-Pacific 7.5.1.Asia Pacific: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.2.Asia Pacific: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.3.Ankylosing Spondylitis Market – China 7.5.3.1. China: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) - 7 -

  8. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 7.5.3.2. China: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.4.Ankylosing Spondylitis Market – India 7.5.4.1. India: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.4.2. India.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.5.Ankylosing Spondylitis Market – Malaysia 7.5.5.1. Malaysia: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.5.2. Malaysia: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.6.Ankylosing Spondylitis Market – Japan 7.5.6.1. Japan: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.6.2. Japan: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.7.Ankylosing Spondylitis Market – Indonesia 7.5.7.1. Indonesia: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.7.2. Indonesia: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.5.8.Ankylosing Spondylitis Market – South Korea 7.5.8.1. South Korea: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.5.8.2. South Korea.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.Ankylosing Spondylitis Market – Middle East & Africa 7.6.1.Middle East & Africa: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.6.2.Middle East & Africa.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.3.Ankylosing Spondylitis Market – Saudi Arabia 7.6.3.1. Saudi Arabia: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.6.3.2. Saudi Arabia.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.4.Ankylosing Spondylitis Market – UAE 7.6.4.1. UAE: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.6.4.2. UAE: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.5.Ankylosing Spondylitis Market – Israel 7.6.5.1. Israel: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) - 8 -

  9. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 7.6.5.2. Israel: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.6.6.Ankylosing Spondylitis Market – South Africa 7.6.6.1. South Africa: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.6.6.2. South Africa: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.7.Ankylosing Spondylitis Market – Latin America 7.7.1.Latin America: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.7.2.Latin America: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.7.3.Ankylosing Spondylitis Market – Mexico 7.7.3.1. Mexico: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.7.3.2. Mexico.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.7.4.Ankylosing Spondylitis Market – Brazil 7.7.4.1. Brazil: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.7.4.2. Brazil.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 7.7.5.Ankylosing Spondylitis Market – Argentina 7.7.5.1. Argentina: Ankylosing Spondylitis Market, By Drug , 2016 – 2028 (USD Million) 7.7.5.2. Argentina.: Ankylosing Spondylitis Market, By Treatment Type, 2016 – 2028 (USD Million) 8.Competitive Landscape 8.1.Expansion and Acquisition Analysis 8.1.1.Expansion 8.2.Partnerships/Collaborations/Agreements/Exhibitions 9.Company Profiles 9.1.AbbVie, Inc. 9.1.1.Company Overview 9.1.2.Financial Performance 9.1.3.Product Benchmarking 9.1.4.Recent Development 9.2.Amgen, Inc. 9.2.1.Company Overview 9.2.2.Financial Performance 9.2.3.Product Benchmarking - 9 -

  10. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 9.2.4.Recent Development 9.3.Pfizer, Inc. 9.3.1.Company Overview 9.3.2.Financial Performance 9.3.3.Product Benchmarking 9.3.4.Recent Development 9.4.Novartis AG 9.4.1.Company Overview 9.4.2.Financial Performance 9.4.3.Product Benchmarking 9.4.4.Recent Development 9.5.Eli Lilly and Company 9.5.1.Company Overview 9.5.2.Financial Performance 9.5.3.Product Benchmarking 9.5.4.Recent Development 9.6.UCB, Inc. 9.6.1.Company Overview 9.6.2.Financial Performance 9.6.3.Product Benchmarking 9.6.4.Recent Development 9.7.Johnson & Johnson Services, Inc. 9.7.1.Company Overview 9.7.2.Financial Performance 9.7.3.Product Benchmarking 9.7.4.Recent Development 9.8.Merck & Co., Inc. 9.8.1.Company Overview 9.8.2.Financial Performance 9.8.3.Product Benchmarking 9.8.4.Recent Development 9.9.Boehringer Ingelheim International GmbH 9.9.1.Company Overview 9.9.2.Financial Performance 9.9.3.Product Benchmarking 9.9.4.Recent Development Access Press Release on Ankylosing Spondylitis Market: https://www.polarismarketresearch.com/press- releases/ankylosing-spondylitis-market About Polaris Market Research - 10 -

  11. Ankylosing Spondylitis Market Size Worth $8.45 Billion By 2028 Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 11 -

More Related